2022
DOI: 10.2337/figshare.19638627
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Once-Weekly Exenatide in Youth With Type 2 Diabetes

Abstract: <p><strong>OBJECTIVE:</strong> Approved treatments for type 2 diabetes in pediatric patients include metformin, liraglutide, and insulin. However, approximately half of the youth fail metformin monotherapy within 1 year, and insulin therapy is associated with challenges. Consequently, the efficacy and safety of once‑weekly injections of exenatide for the treatment of youth with type 2 diabetes was evaluated. </p> <p><strong>RESEARCH DESIGN AND METHODS:</strong> Partici… Show more

Help me understand this report
View published versions

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles